Aslan Pharmaceuticals Limited (ASLN) Annual Balance Sheets

Annual · GAAP · USD millions
Access ASLN quarterly Balance Sheets →
Examining balance sheet movements between Aslan Pharmaceuticals Limited and Dec 31 2019 reveals how Dec 31 2023 adjusts its asset composition and liability profile.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2023)
(Dec 31 2022) (Dec 31 2021) (Dec 31 2020) (Dec 31 2019)
Assets
Cash And Cash Equivalents21.25
Cash & Short-term Investments21.00
Notes Receivable, Current0.00
Other Current Assets2.88
Total Current Assets24.13
Equipment/Property/Plant Net0.03
Intangible Assets0.00
Other Assets, Noncurrent0.47
Prepayments-
Other Current Assets2.88
Financial Assets At Fair Value Through Profit Or Loss-
Investments In Associates-
Intangible Assets Other Than Goodwill0.00
Noncurrent Assets0.50
Total Assets24.63
Liabilities
Short-term Debt24.80
Total Current Liabilities13.11
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent13.11
NoncurrentLiabilities24.80
Current Lease Liabilities0.23
Current Financial Liabilities At Fair Value Through Profit Or Loss0.09
Noncurrent Lease Liabilities-
Total Liabilities37.91
Stockholders' Equity
Other Equity-13.29
Common Stockholder's Equity-13.29
Total Stockholder's Equity-13.29
Liabilities & Stockholder's Equity24.63
4 historic quarters locked

Sign in to unlock the full Aslan Pharmaceuticals Limited balance sheet history.

About Aslan Pharmaceuticals Ltd Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-24-043860

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License